COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Cogent Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$30.01+0.49 (+1.66%)
Close on Oct 19, 2026
- Market cap
- $5.13B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Cogent Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 1, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 5, 2026 | May 5, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 9, 2026 | Apr 23, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 6, 2025 | Dec 8, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 18, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2025 | Nov 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 7, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 5, 2025 | Sep 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 7, 2025 | Jul 7, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Current report | 8-K | May 6, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2025 | Apr 22, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 8, 2024 | Dec 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2024 | Sep 3, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2024 | Aug 6, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 27, 2024 | Jun 27, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2024 | Jun 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2024 | Apr 23, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2024 | Mar 22, 2024 | SEC EDGAR |